ALYSSA ROSSO: Open Payments
NPI 1508477001 · SHELTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 17 payments from 10 companies in 2025. Trend: 2023 $674 · 2024 $235 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 3 | $135 |
| MERZ NORTH AMERICA, INC. | 3 | $95 |
| Exact Sciences Corporation | 2 | $42 |
| CooperSurgical, Inc. | 2 | $41 |
| Organon LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 1 | $35 |
| PFIZER INC. | 1 | $26 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $22 |
| Exeltis, USA Inc. | 1 | $19 |
| MILLICENT US INC | 1 | $17 |
Products named: Xeomin, Paragard T 380A, GEMTESA, ABRYSVO, NEXPLANON, The Cologuard Plus Collection Kit, Cologuard Collection Kit, SLYND.
Industry payments across CT — which companies pay providers there.
